Celgene competitorsClear all
Celgene's top competitors include Amgen, Gilead Sciences, Idorsia, Sanofi and Regeneron Pharmaceuticals.
| Save Comparison |  Amgen Amgen (formerly known as Applied Molecular Genetics) is a biotech company discovering, developing, manufacturing, and delivering human therapeutics products. |  Gilead Sciences Gilead Sciences is a research-based biopharmaceutical company focused on the discovery, development, and commercialization of innovative medicines. |  Idorsia Idorsia, a biopharmaceutical company, discovers, develops, and commercializes drugs for unmet medical needs. |  Regeneron Pharmaceuticals Regeneron Pharmaceuticals is a biopharmaceutical company that develops, manufactures, and markets medicines for the treatment of eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, pain, infectious diseases, and rare diseases. | ||
Founding Date | Founding Date 1986 | Founding Date 1980 | Founding Date 1987 | Founding Date 2017 | Founding Date 2004 | Founding Date 1988 |
Type | Type Subsidiary | Type Public | Type Public | Type Public | Type Public | Type Public |
Tags | ||||||
Locations | Locations Summit, US HQ Singapore, SG Boudry, CH | Locations Thousand Oaks, US HQ Hydra, DZ Vicente López, AR Kew, AU North Ryde, AU Wien, AT Machelen, BE see more | Locations Foster City, US HQ Melbourne, AU København, DK Hod Hasharon, IL Milano, IT Warszawa, PL Dubai, AE see more | Locations Allschwil, CH HQ Shanghai, CN Lörrach, DE Chiyoda City, JP | Locations Tarrytown, US HQ Dublin, IE Limerick, IE Greater London, GB Bernards, US Rensselaer, US Washington, US | |
Employees | Employees 8,85219% increase | Employees 23,4009% increase | Employees 11,8007% increase | Employees 8007% increase | Employees 100,4094% decrease | Employees 8,1009% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) 140.8 b | Valuation ($) 85.5 b | Valuation ($) N/A | Valuation ($) 130.7 b | Valuation ($) 65 b |
Twitter followers | Twitter followers 26.8 k | Twitter followers 91 k | Twitter followers 63.3 k | Twitter followers 895 | Twitter followers 130.6 k | Twitter followers 22.3 k |
Number of tweets (last 30 days) | Number of tweets (last 30 days) N/A | Number of tweets (last 30 days) 53 | Number of tweets (last 30 days) 29 | Number of tweets (last 30 days) 3 | Number of tweets (last 30 days) 53 | Number of tweets (last 30 days) 31 |
Average likes per tweet (last 30 days) | Average likes per tweet (last 30 days) N/A | Average likes per tweet (last 30 days) 8.7 | Average likes per tweet (last 30 days) 29.2 | Average likes per tweet (last 30 days) 8 | Average likes per tweet (last 30 days) 39.3 | Average likes per tweet (last 30 days) 30.4 |
Percentage of tweets with engagement (last 30 days) | Percentage of tweets with engagement (last 30 days) N/A | Percentage of tweets with engagement (last 30 days) 84.91% | Percentage of tweets with engagement (last 30 days) 100% | Percentage of tweets with engagement (last 30 days) 66.67% | Percentage of tweets with engagement (last 30 days) 98.11% | Percentage of tweets with engagement (last 30 days) 100% |
Alexa Website Rank | Alexa Website Rank 318379 | Alexa Website Rank 172816 | Alexa Website Rank 140357 | Alexa Website Rank 403027 | Alexa Website Rank 164692 | Alexa Website Rank 205917 |
Employee Rating | Employee Rating 4 | Employee Rating 3.8 | Employee Rating 3.5 | Employee Rating 3.4 | Employee Rating 3.3 | Employee Rating 3.9 |
Financial | ||||||
Revenue (est.) | Revenue (est.) $15.3b (FY, 2018) | Revenue (est.) $23.4b (FY, 2019) | Revenue (est.) $22.4b (FY, 2019) | Revenue (est.) CHF23.8m (FY, 2019) | Revenue (est.) €37.1b (FY, 2015) | Revenue (est.) $7.9b (FY, 2019) |
Cost of goods | Cost of goods $587m (FY, 2018) | Cost of goods $4.4b (FY, 2019) | Cost of goods $4.7b (FY, 2019) | Cost of goods N/A | Cost of goods €10.9b (FY, 2015) | Cost of goods $782.2m (FY, 2019) |
Gross profit | Gross profit $14.7b (FY, 2018) | Gross profit $19b (FY, 2019) | Gross profit $17.8b (FY, 2019) | Gross profit N/A | Gross profit €26.1b (FY, 2015) | Gross profit $7.1b (FY, 2019) |
Net income | Net income $4b (FY, 2018) | Net income $7.8b (FY, 2019) | Net income $5.4b (FY, 2019) | Net income (CHF494.6m) (FY, 2019) | Net income €4.4b (FY, 2015) | Net income $2.1b (FY, 2019) |
Operating ⚠ | ||||||
Countries | Countries N/A | Countries 100 (FY, 2019) | Countries 35 (FY, 2019) | Countries N/A | Countries N/A | Countries N/A |
Patents (EU) | Patents (EU) N/A | Patents (EU) 21 (FY, 2019) | Patents (EU) N/A | Patents (EU) N/A | Patents (EU) N/A | Patents (EU) 11 (FY, 2019) |
Patents (US) | Patents (US) N/A | Patents (US) 34 (FY, 2019) | Patents (US) N/A | Patents (US) N/A | Patents (US) N/A | Patents (US) 21 (FY, 2019) |
Phase III Trials Products | Phase III Trials Products N/A | Phase III Trials Products 14 (Feb, 2020) | Phase III Trials Products N/A | Phase III Trials Products N/A | Phase III Trials Products 7 (Y, 2016) | Phase III Trials Products N/A |
Products | Products N/A | Products N/A | Products 24 (FY, 2019) | Products N/A | Products N/A | Products 7 (FY, 2019) |
Projects in R&D Pipeline | Projects in R&D Pipeline N/A | Projects in R&D Pipeline N/A | Projects in R&D Pipeline N/A | Projects in R&D Pipeline 12 (FY, 2019) | Projects in R&D Pipeline 43 (Y, 2016) | Projects in R&D Pipeline N/A |
Funding | ||||||
Total funding raised | Total funding raised N/A | Total funding raised $ 175.5m | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 310m | Total funding raised $ 8.9m |
For sources of this data, please see the company profile
View company profiles
Amgen
HQ
Thousand Oaks, US
Employees
23,400↑ 9% increase
Amgen (formerly known as Applied Molecular Genetics) is a biotech company discovering, developing, manufacturing, and delivering human therapeutics products.
View companyGilead Sciences
HQ
Foster City, US
Employees
11,800↑ 7% increase
Gilead Sciences is a research-based biopharmaceutical company focused on the discovery, development, and commercialization of innovative medicines.
View companyIdorsia
HQ
Allschwil, CH
Employees
800↑ 7% increase
Idorsia, a biopharmaceutical company, discovers, develops, and commercializes drugs for unmet medical needs.
View company
Sanofi
HQ
Paris, FR
Employees
100,409↓ 4% decrease
Sanofi is a company providing healthcare solutions.
View company